Literature DB >> 17825628

Estimating the age of CFTR mutations predominantly found in Brittany (Western France).

Yann Fichou1, Emmanuelle Génin, Cédric Le Maréchal, Marie-Pierre Audrézet, Virginie Scotet, Claude Férec.   

Abstract

BACKGROUND: Disparities in the spectrum of mutations within the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) gene are commonly observed in populations from different ethnical and/or geographical origins. The occurrence of CF in Brittany (western France) is one of the highest in populations from Caucasian origin (<1/2000 in specific areas). The W846X(2), 1078delT and G551D mutations, as well as the I1027T polymorphism in cis with the DeltaF508 mutation (currently referred to as p.F508del) are particularly frequent in this area. We investigated the age of the respective variants in the region of interest.
METHODS: Several polymorphic markers surrounding the CFTR gene were genotyped. Allele frequencies as well as mutation rates and other parameters were used to calculate the respective age of the most recent common ancestors in the region of interest by a previously employed, simple likelihood-based method.
RESULTS: Following haplotype reconstruction and simulation, the ages were estimated to be approximately 600, 1000, 1200 and 600 years, respectively (with a 95% confidence interval).
CONCLUSIONS: These datings thus provide historical insights in the context of understanding population migrations. They also underline the usefulness of this method for estimating the age of rare mutations with a limited number of carriers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17825628     DOI: 10.1016/j.jcf.2007.07.009

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  5 in total

1.  CFTR mutation analysis and haplotype associations in CF patients.

Authors:  S K Cordovado; M Hendrix; C N Greene; S Mochal; M C Earley; P M Farrell; M Kharrazi; W H Hannon; P W Mueller
Journal:  Mol Genet Metab       Date:  2011-10-26       Impact factor: 4.797

2.  The novel complex allele [A238V;F508del] of the CFTR gene: clinical phenotype and possible implications for cystic fibrosis etiological therapies.

Authors:  Anna Diana; Angela Maria Polizzi; Teresa Santostasi; Luigi Ratclif; Maria Giuseppina Pantaleo; Giuseppina Leonetti; Danila Rosa Iusco; Crescenzio Gallo; Massimo Conese; Antonio Manca
Journal:  J Hum Genet       Date:  2016-02-25       Impact factor: 3.172

3.  Estimating the age of p.(Phe508del) with family studies of geographically distinct European populations and the early spread of cystic fibrosis.

Authors:  Philip Farrell; Claude Férec; Milan Macek; Thomas Frischer; Sabine Renner; Katharina Riss; David Barton; Teresa Repetto; Maria Tzetis; Karine Giteau; Morten Duno; Melissa Rogers; Hara Levy; Mourad Sahbatou; Yann Fichou; Cédric Le Maréchal; Emmanuelle Génin
Journal:  Eur J Hum Genet       Date:  2018-08-08       Impact factor: 4.246

4.  Deep resequencing of CFTR in 762 F508del homozygotes reveals clusters of non-coding variants associated with cystic fibrosis disease traits.

Authors:  Briana Vecchio-Pagán; Scott M Blackman; Melissa Lee; Melis Atalar; Matthew J Pellicore; Rhonda G Pace; Arianna L Franca; Karen S Raraigh; Neeraj Sharma; Michael R Knowles; Garry R Cutting
Journal:  Hum Genome Var       Date:  2016-11-24

5.  High frequency of complex CFTR alleles associated with c.1521_1523delCTT (F508del) in Russian cystic fibrosis patients.

Authors:  Nika V Petrova; Nataliya Y Kashirskaya; Tatyana A Vasilyeva; Natalia V Balinova; Andrey V Marakhonov; Elena I Kondratyeva; Elena K Zhekaite; Anna Y Voronkova; Sergey I Kutsev; Rena A Zinchenko
Journal:  BMC Genomics       Date:  2022-04-01       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.